WASHINGTON, Dec 8 (Reuters) - A fledgling social media platform has asked the U.S. Patent and Trademark Office to cancel trademarks for Twitter so it can take them for itself, contending that ...

Yann LeCun, the artificial intelligence pioneer who is leaving Meta Platforms Inc. at the end of the year, said Meta will not financially back his new AI company and hinted it could be based in Paris.

Financial giants have made a conspicuous bullish move on Advanced Micro Devices. Our analysis of options history for Advanced Micro Devices (NASDAQ:AMD) revealed 29 unusual trades. Delving into the ...

Liverpool could be turned upside down after reports of 'advanced talks'. The Reds' landscape is shifting rapidly. Liverpool face a battle to find the right group of centre-backs in 2026. That's ...

PALO ALTO, Calif.—On a quiet residential street a few blocks from Stanford University, two former Google researchers are launching a startup they hope will remake the $800 billion chip industry. Anna ...

Marvell Technology, Inc. (NASDAQ: MRVL) is pushing deeper into the artificial intelligence hardware arms race, with a potential multi-billion-dollar deal to acquire a photonics startup that could ...

Dec 1 (Reuters) - U.S. chipmaker Marvell Technology (MRVL.O), opens new tab is in advanced talks to acquire chip startup Celestial AI in a cash-and-stock deal worth multiple billions of dollars, the ...

A quiet epidemic haunts the glowing screens of this globally connected world: digital loneliness. People possess thousands of friends across social platforms yet feel profoundly isolated. The very ...

Imfinzi (durvalumab) is an immunotherapy medicine that helps the immune system detect and attack cancer cells. The FDA has approved a combination of Imfinzi and standard chemotherapy medicines – ...

This is an edition of The Wonder Reader, a newsletter in which our editors recommend a set of stories to spark your curiosity and fill you with delight. Sign up here to get it every Saturday morning.